Sodium dodecyl sulfate induces plasminogen activator inhibitor type 2 expression in epidermal keratinocytes in vivo and in vitro

Journal of Investigative Dermatology

Volumn 117, Issue 3, 2001, Pages 647-653

  Chung, Nancy M ^a   Marshall, Christine M ^a   Leyden, James J ^a   Lavker, Robert M ^a   Jensen, Pamela J ^a   Risse Marsh, Barbara C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DETERGENT; DODECYL SULFATE SODIUM; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; DRUG ACTIVITY; DRUG EFFECT; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SKIN;

EID: 0034797522     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01428.x     Document Type: Article

References (51)

1. Sodium lauryl sulfate for irritant patch testing - A dose-response study using bioengineering methods for determination of skin irritation
2. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro
3. Plasminogen activator inhibitor type 2 is expressed in keratinocytes during re-epithelialization of epidermal defects
4. Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activator inhibitor 2
5. Expression of skin-derived antileukoproteinase (SKALP) in reconstructed human epidermis and its value as a marker for skin irritation
6. Use of XXT-assay to assess the cytotoxicity of different surfactants and metal salts in human keratinocytes (HaCat). A feasible method for in vitro testing of skin irritants
7. Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system
8. The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss
9. trans-4-(aminomethyl) cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans
10. Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: Effect of sodium dodecyl sulphate
11. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption
12. The stratum corneum revisited
13. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient
14. A comparative study of the cytotoxicity of skin irritants on cultured human oral and skin keratinocytes
15. Characterization of detergent-induced barrier alterations - Effect of barrier cream on irritation
16. Sodium lauryl sulphate penetration in an in vitro model using human skin
17. Relationship of epidermal lipogenesis to cutaneous barrier function
18. Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2
19. Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo
20. 86, essential for transglutaminase-mediated cross-linking
21. Plasminogen activator inhibitor type 2: An intracellular keratinocyte differentiation product that is incorporated into the cornified envelope
22. E-cadherin and P-cadherin have partially redundant roles in human epidermal stratification
23. Localization of plasminogen activators and plasminogen activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization
24. Human keratinocytes are a source for tumor necrosis factor α: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light
25. Biological and clinical aspects of plasminogen activator inhibitor type 2
26. Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate
27. The sodium lauryl sulfate model: An overview
28. Differential effects of sodium lauryl sulfate and non-anoic acid on the expression of CD1a and ICAM-1 in human epidermis
29. Nickel and skin irritants up-regulate tumor necrosis factor-alpha RNA in keratinocytes by different but potentially synergistic mechanisms
30. Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis
31. Changes in keratinocyte maturation during wound healing
32. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin
33. Quantification of sodium lauryl sulfate penetration into the skin and underlying tissue after topical application - Pharmacological and toxicological implications
34. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia
35. Binding and activation of plasminogen at the surface of human keratinocytes
36. The ovalbumin family of serpin proteins
37. Differentiating cells of murine stratified squamous epithelia constitutively express plasminogen activator inhibitor type 2 (PAI-2)
38. Evidence for intracellular cleavage of plasminogen activator type 2 (PAI-2) in normal epidermal keratinocytes
39. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes
40. Differential effects of detergents on keratinocyte gene expression
41. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis
42. Keratinocyte-specific transglutaminase of cultured human epidermal cells: Relation to cross-linked envelope formation
43. Permeability barrier disruption alters the localization and expression of TNFα/protein in the epidermis
44. Susceptibility to irritants: Role of barrier function, skin dryness and history of atopic dermatitis
45. Regulation of the level and the glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation
46. SLS-irritated human skin shows no correlation between degree of proliferation and TEWL increase
47. Epidermal damage induced by irritants in man: A light and electron microscopic study
48. Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants
49. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice
50. Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis